Suprathel Demonstrates Superior Outcomes Compared to Biobrane in Pediatric Partial-Thickness Burns
Suprathel is associated with significantly better outcomes than Biobrane for pediatric partial-thickness burns, with shorter hospital stays (4 vs 9 days), lower rates of escharectomy and grafting (21.1% vs 32.1%), and reduced need for long-term reintervention (18.5% vs 26.2%). 1
Key Outcome Differences
The 2024 European Journal of Pediatrics study 1 provides the most direct head-to-head comparison and demonstrates clear superiority of Suprathel across multiple clinically meaningful endpoints:
Hospital Length of Stay
- Suprathel: Median 4 days (IQR 2-9)
- Biobrane: Median 9 days (IQR 7-14)
- This represents a 56% reduction in hospitalization time
Acute Management Outcomes
- Escharectomy and grafting rate during acute phase:
- Suprathel: 21.1%
- Biobrane: 32.1%
- This 11% absolute difference indicates better preservation of viable tissue with Suprathel
Long-Term Quality of Life Impact
- Reintervention rate at follow-up:
- Suprathel: 18.5%
- Biobrane: 26.2%
- The lower reintervention rate suggests better functional and aesthetic outcomes, directly impacting long-term quality of life
Study Quality and Applicability
The comparative study 1 included 378 pediatric patients (92 Suprathel, 107 Biobrane, 179 EZ-derm) with no significant differences in baseline demographics or burn characteristics between groups, making the comparison valid. This retrospective cohort from 2015-2021 represents contemporary practice patterns.
Important caveat: While Biobrane shows efficacy compared to traditional dressings—with one 2025 meta-analysis 2 demonstrating 5.2 days faster healing and 2 days shorter hospital stays versus standard dressings—these benefits are modest compared to Suprathel's performance.
Clinical Implications for Morbidity and Mortality
The reduced need for escharectomy and grafting with Suprathel (21.1% vs 32.1%) has direct implications for:
- Reduced surgical morbidity (fewer anesthetic exposures, less blood loss)
- Lower infection risk (fewer invasive procedures)
- Better cosmetic outcomes (preservation of native tissue when possible)
- Reduced psychological trauma (fewer procedures, shorter hospitalization)
Practical Considerations
A 2025 study 3 identified risk factors for premature Suprathel detachment:
- Patient age (younger children at higher risk)
- Burn location (certain anatomical sites more problematic)
- Correlation with burn depth progression
Despite these limitations, only 13% of patients required surgical revision after material detachment, and the overall outcomes remained superior to alternatives.
Algorithm for Decision-Making
For pediatric partial-thickness burns after tangential excision, use Suprathel as first-line treatment based on:
- Superior reduction in hospital stay (prioritizes family burden and healthcare costs)
- Lower grafting requirements (reduces surgical morbidity)
- Decreased long-term reintervention needs (improves quality of life)
Reserve Biobrane for situations where Suprathel is unavailable or cost-prohibitive, as it still outperforms traditional dressings but provides inferior outcomes compared to Suprathel.